These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5053584)
41. Potentiation of the antitumor effect of 5-fluorouracil by some nucleotides, and their possible role in the potentiation. Tezuka M; Tamemasa O Jpn J Exp Med; 1983 Jun; 53(3):155-63. PubMed ID: 6663806 [TBL] [Abstract][Full Text] [Related]
42. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine. Ingraham HA; Tseng BY; Goulian M Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571 [TBL] [Abstract][Full Text] [Related]
43. Phosphorus incorporation in the Ehrlich ascites tumor cell. Levinson C; Gordon ED J Cell Physiol; 1971 Oct; 78(2):257-64. PubMed ID: 5156707 [No Abstract] [Full Text] [Related]
44. Nucleoside antibiotics. I. Biochemical tools for studying the structural requirements for interaction at the catalytic and regulatory sites of ribonucleotide reductase from Lactobacillus leichmannii. Suhadolnik RJ; Finkel SI; Chassy BM J Biol Chem; 1968 Jun; 243(12):3552-7. PubMed ID: 5656392 [No Abstract] [Full Text] [Related]
50. The formation of uridine diphosphate-2-deoxy-D-glucose in yeast. Biely P; Bauer S Biochim Biophys Acta; 1966 May; 121(1):213-4. PubMed ID: 5956946 [No Abstract] [Full Text] [Related]
51. Synthesis and degradation fo UDP-glucuronic acid in the hyalocytes of calf vitreous. Jacobson B Exp Eye Res; 1967 Oct; 6(4):332-5. PubMed ID: 6060544 [No Abstract] [Full Text] [Related]
52. Promotion of purine nucleotide binding to thymidylate synthase by a potent folate analogue inhibitor, 1843U89. Weichsel A; Montfort WR; Cieśla J; Maley F Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3493-7. PubMed ID: 7724588 [TBL] [Abstract][Full Text] [Related]
53. Biochemical and genetic basis of the response to 5-fluorouracil in Drosophila melanogaster. O'Byrne-Ring N; Duke E Biochem Genet; 1980 Aug; 18(7-8):717-26. PubMed ID: 6451215 [TBL] [Abstract][Full Text] [Related]
54. 5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia. Roobol C; De Dobbeleer GB; Bernheim JL Br J Cancer; 1984 Jun; 49(6):739-44. PubMed ID: 6234011 [TBL] [Abstract][Full Text] [Related]
55. 5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole. Maehara Y; Sakaguchi Y; Takahashi I; Yoshida M; Kusumoto H; Masuda H; Sugimachi K Cancer Chemother Pharmacol; 1992; 29(4):257-60. PubMed ID: 1537070 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of single-agent therapy in human colorectal tumour xenografts. Houghton PJ; Houghton JA Br J Cancer; 1978 May; 37(5):833-40. PubMed ID: 656310 [TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy. Sadee W; Wong CG Clin Pharmacokinet; 1977; 2(6):437-50. PubMed ID: 589882 [TBL] [Abstract][Full Text] [Related]
58. Effects of 5-fluorouracil on the cell kinetic and growth parameters of hepatoma 3924A. Kovacs CJ; Hopkins HA; Simon RM; Looney WB Br J Cancer; 1975 Jul; 32(1):42-50. PubMed ID: 169869 [TBL] [Abstract][Full Text] [Related]